findmyKOL

Maria Padilla, MD

Enriched profile

Professor of Medicine, Pulmonary, Critical Care and Sleep Medicine; Director, Advanced Lung Disease/Interstitial Lung Disease Program · Icahn School of Medicine at Mount Sinai

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 New York, NY · Northeast · United StatesSpecialtyPulmonary DiseaseFocusIdiopathic Pulmonary Fibrosis
Active KOLfindmyKOL type: NationalLatest publicationSee ScholarshipOnline presenceverified 2026Payments2021–2025NIH funding1985–1986Why? →

Maria Padilla is Professor of Medicine, Pulmonary, Critical Care and Sleep Medicine; Director, Advanced Lung Disease/Interstitial Lung Disease Program at Icahn School of Medicine at Mount Sinai. OpenAlex indexes 108 publications with 4,056 citations (h-index 32); ClinicalTrials.gov lists 6 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 16 Oct 2026

Maria L. Padilla, MD, is Professor of Medicine, Pulmonary, Critical Care and Sleep Medicine at Icahn School of Medicine at Mount Sinai. The public record shows 108 publications with 4,056 citations (h-index 32), centered on Idiopathic Pulmonary Fibrosis. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 6 companies, 1 NIH-funded awards (1985–1986).

  • Top research focus: Idiopathic Pulmonary Fibrosis
  • 6 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 6 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Idiopathic Pulmonary Fibrosis6 trialsLung Diseases, Interstitial1 trial

Research focus

OpenAlex concept fingerprint
Idiopathic Pulmonary Fibrosis

Drugs & molecules

across trials, industry payments and publications
Tyvasogeneric · TreprostinilClinical trials—Industry payments10Publications—Esbrietgeneric · PirfenidoneClinical trials—Industry payments4Publications—Ofevgeneric · NintedanibClinical trials—Industry payments3Publications—Xolairgeneric · OmalizumabClinical trials—Industry payments2Publications—Arikaycegeneric · AmikacinClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
United Therapeutics CorporationClinical trials—Industry payments23Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments15Genentech USA, Inc.Clinical trials—Industry payments9Electromed, Inc.Clinical trials—Industry payments8Boehringer Ingelheim International GmbHClinical trials—Industry payments2Avalyn Pharma Inc.Clinical trials1Industry payments—Cumberland PharmaceuticalsClinical trials1Industry payments—Duke UniversityClinical trials1Industry payments—Icahn School of Medicine at Mount SinaiClinical trials1Industry payments—Insmed, Inc.Clinical trials—Industry payments1National Jewish HealthClinical trials1Industry payments—Rein TherapeuticsClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
108publications

Distinct works indexed by OpenAlex, matched via ORCID.

4,056citations

Total citations across indexed works.

32h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6clinical trials

Investigator role on registered studies.

View trials ↓
6companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 1985–1986

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 16 Oct 2026

6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    35.4%
    Corticosteroid24%
    Trelegy Ellipta55%Breo Ellipta31%Fluticasone Propionate7%Qvar Redihaler7%
    Part D<11 patients
    beta2-Adrenergic Agonist6%
    Albuterol Sulfate Hfa100%
    Part D≥17 patients

    + 2 more classes in this area

  • Cancer & immunology

    30%
    Kinase inhibitor17.6%
    Ofev100%
    Part D≥26 patients
    Pyridone12.4%
    Pirfenidone100%
    Part D≥20 patients
  • Metabolism & gastrointestinal

    21.5%
    Corticosteroid11.1%
    Prednisone100%
    Part D≥40 patients
    Proton pump inhibitor8.5%
    Omeprazole87%Esomeprazole Magnesium13%
    Part D<11 patients

    + 1 more class in this area

All 6 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)98% facility · 2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 16 Oct 2026

1 NIH research award on record, funded 1985–1986 per NIH RePORTER. The latest:

Publications

None on file yet. We only list publications we can confidently match to this person. Why? →

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/maria-padilla-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • Other

    scholars.mssm.edu/en/persons/maria-padilla

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.mssm.edu ↗

Mentions by others

where others cite or feature them
  • Other

    ajmc.com/view/key-ild-topics-at-mount-sinai-s-advances-in-pulmonary-medicine-2024

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ajmc.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Mount Sinai School of Medicine

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rheumatologyacademy.org ↗

Editorial & leadership roles

journal and society appointments
  • Medical Director

    Lung Transplantation Program, The Mount Sinai Medical Center

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
  • Director

    Interstitial Lung Disease Program, Mount Sinai - National Jewish Health Respiratory Institute

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
  • Board certified: Internal Medicine

    Pulmonary Medicine, Critical Care Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.mssm.edu ↗
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.